Literature DB >> 7480517

Response to smoking as a function of prior smoking amounts.

R V Fant1, K J Schuh, M L Stitzer.   

Abstract

Smoking patterns are changing to accommodate new environmental smoking restrictions. The current study explored the effects of prior smoking amounts on the behavioral, physiological, and subjective effects of smoking a single cigarette. Ten smokers (six females, four males) each participated in four laboratory sessions of 6 h duration. During each session, they smoked 0, 2, 5, or 11 cigarettes which were evenly spaced throughout the 6-h period at intervals ranging from 30 min (11 cigarettes) to 120 min (2 cigarettes), with condition order determined by a Latin square. At the end of each session, all smoked a final cigarette. Response to the last cigarette of the 6-h session was influenced by pretreatment smoking amounts. Number of puffs drawn from the cigarette (15.0, 14.1, 13.3, and 10.1) was inversely related to prior smoking density, as was heart rate increase (5.8, 4.0, 2.4, and 1.3 bpm). Three physical symptoms of smoking, dizzy, lightheaded and tingling, were significantly greater when preceded by 6 h of no smoking than when preceded by smoking at 30-min intervals. However, these symptoms were rated as mild (19-27 on a 100-point scale) even when no cigarettes had been smoked. These results suggest some dissipation of acute tolerance after 6 h of smoking abstinence. Liking and satisfaction ratings were inversely related to the pretreatment density of smoking. Liking scores for the last cigarette were 85, 71, 68 and 48 (on a 100-point analog scale) when 0, 2, 5 and 11 cigarettes had been smoked. Overall, the study showed that physiological and subjective effects of smoking are modulated by recent histories of smoking.(ABSTRACT TRUNCATED AT 250 WORDS)

Mesh:

Substances:

Year:  1995        PMID: 7480517     DOI: 10.1007/bf02245853

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  The development and initial validation of a questionnaire on smoking urges.

Authors:  S T Tiffany; D J Drobes
Journal:  Br J Addict       Date:  1991-11

2.  Cardiovascular and subjective effects of smoking before and after 24 h of abstinence from cigarettes.

Authors:  R J West; M A Russell
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Pharmacodynamic model of tolerance: application to nicotine.

Authors:  H C Porchet; N L Benowitz; L B Sheiner
Journal:  J Pharmacol Exp Ther       Date:  1988-01       Impact factor: 4.030

4.  Influence of tobacco abstinence on the disposition kinetics and effects of nicotine.

Authors:  B L Lee; N L Benowitz; P Jacob
Journal:  Clin Pharmacol Ther       Date:  1987-04       Impact factor: 6.875

5.  Drop in heart rate following smoking cessation may be permanent.

Authors:  R West; N Schneider
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Effects of a restricted work-site smoking policy on employees who smoke.

Authors:  J Brigham; J Gross; M L Stitzer; L J Felch
Journal:  Am J Public Health       Date:  1994-05       Impact factor: 9.308

7.  Interindividual variability in the metabolism and cardiovascular effects of nicotine in man.

Authors:  N L Benowitz; P Jacob; R T Jones; J Rosenberg
Journal:  J Pharmacol Exp Ther       Date:  1982-05       Impact factor: 4.030

8.  Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment.

Authors:  K O Fagerström
Journal:  Addict Behav       Date:  1978       Impact factor: 3.913

9.  Acute tolerance to nicotine in smokers: lack of dissipation within 2 hours.

Authors:  K A Perkins; J E Grobe; S L Mitchell; J Goettler; A Caggiula; R L Stiller; A Scierka
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

10.  Human cigarette smoking: effects of puff and inhalation parameters on smoke exposure.

Authors:  J P Zacny; M L Stitzer; F J Brown; J E Yingling; R R Griffiths
Journal:  J Pharmacol Exp Ther       Date:  1987-02       Impact factor: 4.030

View more
  9 in total

1.  Methodological considerations in nicotine research: the use of "denicotinised" cigarettes as the control condition in smoking studies.

Authors:  J M Rusted; L Graupner; K Greenwood
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

2.  Predictors of smoking lapse in a human laboratory paradigm.

Authors:  Daniel J O Roche; Spencer Bujarski; Nathasha R Moallem; Iris Guzman; Jenessa R Shapiro; Lara A Ray
Journal:  Psychopharmacology (Berl)       Date:  2014-02-06       Impact factor: 4.530

3.  Immediate hedonic response to smoking lapses: relationship to smoking relapse, and effects of nicotine replacement therapy.

Authors:  Saul Shiffman; Stuart G Ferguson; Chad J Gwaltney
Journal:  Psychopharmacology (Berl)       Date:  2005-11-11       Impact factor: 4.530

Review 4.  Hormones, nicotine, and cocaine: clinical studies.

Authors:  Nancy K Mello
Journal:  Horm Behav       Date:  2009-10-14       Impact factor: 3.587

5.  Tobacco smoking produces widespread dominant brain wave alpha frequency increases.

Authors:  Edward F Domino; Lisong Ni; Michael Thompson; Huilei Zhang; Hiroki Shikata; Hiromi Fukai; Takeshi Sakaki; Ippei Ohya
Journal:  Int J Psychophysiol       Date:  2009-09-15       Impact factor: 2.997

Review 6.  Nicotine psychobiology: how chronic-dose prospective studies can illuminate some of the theoretical issues from acute-dose research.

Authors:  Andrew C Parrott
Journal:  Psychopharmacology (Berl)       Date:  2006-02-07       Impact factor: 4.530

Review 7.  More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.

Authors:  M J Moerke; L R McMahon; J L Wilkerson
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

8.  Cigarette-by-cigarette satisfaction during ad libitum smoking.

Authors:  Saul Shiffman; Thomas R Kirchner
Journal:  J Abnorm Psychol       Date:  2009-05

9.  Rapid nicotine tolerance and cross-tolerance to varenicline in rhesus monkeys: Drug discrimination.

Authors:  Megan J Moerke; Lance R McMahon
Journal:  Exp Clin Psychopharmacol       Date:  2018-08-13       Impact factor: 3.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.